Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06894849 · ClinicalTrials.gov registry record · NA

Text -Based Depression Screening Among Cancer Survivors

A NA study of Cancer and Cancer Survivor, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06894849 is a NA study of Cancer and Cancer Survivor that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06894849, a NA study of Cancer and Cancer Survivor, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

Depression is common among cancer survivors, but current screening methods are not always effective. To help improve depression screening for cancer survivors, this study will conduct a pilot randomized controlled trial (RCT) with 60 participants. The goal is to evaluate whether a text message-based approach to depression screening is feasible, acceptable, and potentially more effective than the current standard of care.

Interventions

  • BEHAVIORAL Text-based depression screening
  • BEHAVIORAL Usual care (UC)

Study Locations (2)

South Carolina

  • Medical University of South Carolina - Charleston
  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-05
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT06894849

The ClinicalTrials.gov registry entry for NCT06894849 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Text-based depression screening is the first listed.

NCT06894849 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06894849 about?

NCT06894849 is a clinical study titled "Text -Based Depression Screening Among Cancer Survivors". Depression is common among cancer survivors, but current screening methods are not always effective. To help improve depression screening for cancer survivors, this study will conduct a pilot randomized controlled trial (RCT) with 60 participants. The goal is to evaluate whether a text message-based...

What is the current status of trial NCT06894849?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-05. Estimated completion is 2026-06-30.

What conditions does trial NCT06894849 study?

This clinical trial studies the following conditions: Cancer, Cancer Survivor, Depression Secondary to Other Disease.

What interventions are being tested in trial NCT06894849?

The interventions under investigation include: Text-based depression screening (BEHAVIORAL), Usual care (UC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06894849?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06894849 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.